The Pharma Industry Awards UK 2026, held in association with title sponsor Kuehne+Nagel at the Park Plaza London Riverbank, brought together 295 guests from across the UK pharmaceutical and life sciences sector for an evening that presented 25 trophies and marked the most significant year of growth in the programme's history. Entries increased by 55 per cent on 2025 and attendance climbed 12 per cent year on year, reflecting the accelerating momentum of a programme now firmly established as the UK industry's premier celebration of pharmaceutical excellence, innovation, and leadership.

Ethypharm was named Pharma Industry Company of the Year, sponsored by Kuehne+Nagel, recognised for its Transitioning from Compliance to Culture programme at its Romford facility in Essex, where over 400 employees specialise in treatments for severe and chronic pain, opioid addiction, and critical care and mental health conditions. The company also claimed the Health and Safety Award on the night. Nige Hilton, VP Global Head of Manufacturing at CSL Seqirus, received the Pharma Leader 2026 award, expressing that the recognition was both surprising and humbling, and dedicating it to the people who had supported, challenged, and inspired him throughout his career. The Pharma Company of the Year award, sponsored by Paradigm Shift Consulting, went to Ipsen Biopharm for its Wrexham site, the company's neuroscience centre of excellence, where 500 employees delivered record output with zero stock-outs in 2025.

Across the other categories, Greywolf Therapeutics won Biotech Company of the Year, Upperton Pharma Solutions claimed both Pharma Contract Services Company of the Year and the Quality Assurance and Control Award, and Sanofi's COPD Health Inequalities Improvement Programme in Hastings Place was recognised for both Partnership and Collaboration of the Year and Pharma Project of the Year. AstraZeneca Macclesfield claimed two awards, taking Sustainability Initiative of the Year for its Where Climate Action Meets Patient Impact programme and Best Use of Technology for its work modernising bio-decontamination with novel enzyme indicator technology. Fujifilm Biotechnologies won Innovation of the Year in the Large category and the Pharma Education and Graduate Training Award, while Flow Health Science took both Best Emerging Pharma Company and Innovation of the Year in the Small category. Avacta Group claimed the Research and Development Achievement Award for its pre|CISION® platform, Karen Adams of Peli BioThermal received the Women in Pharma Award, and Paradigm Shift Consulting was recognised with the Diversity, Equality and Inclusion Strategy Award.

The event was delivered with the support of title sponsor Kuehne+Nagel, Platinum sponsor Equans Sci-Tech, and Gold sponsors Csafe, Paradigm Shift Consulting, Envirotainer, QuickStat, FujiFilm Biotechnologies, SkyCell, Delta Air Lines Inc. CARGO, DSV Air and Sea Limited, and Superscript, alongside supporters BioNow and Amárach Research. Fabien Charrier, Director of Air Logistics Development at Kuehne+Nagel, noted that the awards provide an important platform to recognise innovation, operational achievement, and industry leadership, celebrating the individuals and organisations whose work is advancing healthcare, strengthening global supply chains, and delivering positive impact for patients worldwide.

Stay tuned for the Pharma Industry Awards UK 2027 cycle, where pharmaceutical and life sciences organisations from across the United Kingdom will once again have the opportunity to submit their most significant achievements for independent recognition.

View the full list of winners at pharmaawards.co.uk/shortlist, and subscribe to the newsletter to stay informed on future award cycles and industry news.